The DOI matches its Crossref record; 106 of the 107 references it cites were found in a registry or an index.
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
Open accessAbstract
BACKGROUND AND AIMS: Vibration-controlled transient elastography (VCTE), point shear wave elastography (pSWE), 2-dimensional shear wave elastography (2DSWE), magnetic resonance elastography (MRE), and magnetic resonance imaging (MRI) have been proposed as non-invasive tests for patients with non-alcoholic fatty liver disease (NAFLD). This study evaluated their diagnostic accuracy for liver fibrosis and non-alcoholic steatohepatitis (NASH). METHODS: PubMED/MEDLINE, EMBASE and the Cochrane Library were searched for studies examining the diagnostic accuracy of these index tests, against histology as the reference standard, in adult patients with NAFLD. Two authors independently screened and assessed methodological quality of studies and extracted data. Summary estimates of sensitivity, specificity and area under the curve (sAUC) were calculated for fibrosis stages and NASH, using a random effects bivariate logit-normal model. RESULTS: We included 82 studies (14,609 patients). Meta-analysis for diagnosing fibrosis stages was possible in 53 VCTE, 11 MRE, 12 pSWE and 4 2DSWE studies, and for diagnosing NASH in 4 MRE studies. sAUC for diagnosis of significant fibrosis were: 0.83 for VCTE, 0.91 for MRE, 0.86 for pSWE and 0.75 for 2DSWE. sAUC for diagnosis of advanced fibrosis were: 0.85 for VCTE, 0.92 for MRE, 0.89 for pSWE and 0.72 for 2DSWE. sAUC for diagnosis of cirrhosis were: 0.89 for VCTE, 0.90 for MRE, 0.90 for pSWE and 0.88 for 2DSWE. MRE had sAUC of 0.83 for diagnosis of NASH. Three (4%) studies reported intention-to-diagnose analyses and 15 (18%) studies reported diagnostic accuracy against pre-specified cut-offs. CONCLUSIONS: When elastography index tests are acquired successfully, they have acceptable diagnostic accuracy for advanced fibrosis and cirrhosis. The potential clinical impact of these index tests cannot be assessed fully as intention-to-diagnose analyses and validation of pre-specified thresholds are lacking. LAY SUMMARY: Non-invasive tests that measure liver stiffness or use magnetic resonance imaging (MRI) have been suggested as alternatives to liver biopsy for assessing the severity of liver scarring (fibrosis) and fatty inflammation (steatohepatitis) in patients with non-alcoholic fatty liver disease (NAFLD). In this study, we summarise the results of previously published studies on how accurately these non-invasive tests can diagnose liver fibrosis and inflammation, using liver biopsy as the reference. We found that some techniques that measure liver stiffness had a good performance for the diagnosis of severe liver scarring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Several substantial comparative studies have shown that MRE provides at least equal quality in fi brosis staging as ultrasound-based elastography techniques.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Self-citationDesign and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965
Self-citationProgression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease
Castera, L., Friedrich-Rust, M., & Loomba, R. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.036 · Cited by 1,494
Eddowes, P. J., Sasso, M., Allison, M., Tsochatzis, E. A., Anstee, Q. M., Sheridan, D. A., Guha, I. N., Cobbold, J., Deeks, J. J., Paradis, V., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.042 · Cited by 1,425
Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, H. L.-Y., Le Bail, B., Choi, P. C.-L., Kowo, M., Chan, A. W.-H., Merrouche, W., et al. (2010) · Hepatology · doi:10.1002/hep.23312 · Cited by 1,322
Research works printed but not linked: 4
- Al Juboori, 2018, The utility of liver elastography in evaluation of liver fibrosis in obese patients undergoing bariatric surgery, Hepatology, 68
- Clet, 2018, Expanding the Use of the VCTE XL probe in morbid obese patients: validation of a new automated adaptive measurement depths algorithm in a large UK multicenter cohort, Hepatology, 68
- Hee, 2014, Comparison of NAFLD Fibrosis Score (NFS) and transient elastography (Fibroscan), alone and in combination, as non-invasive methods for the evaluation of fibrosis in non-alcoholic fatty liver disease (NAFLD), J Gastroenterol Hepatol, 29, 76
- Pais, 2011, Validation of a simple algorithm combining serum markers and elastometry for the diagnosis of fibrosis in NAFLD, Hepatology, 54
Cited by
Sorted by citations
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
Sangro, B., Argemi, J., Ronot, M., Paradis, V., Meyer, T., Mazzaferro, V., Jepsen, P., Golfieri, R., Galle, P., Dawson, L., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.028 · Cited by 985
Kaplan, D. E., Ripoll, C., Thiele, M. S., Fortune, B. E., Simonetto, D. A., García–Tsao, G., & Bosch, J. (2023) · Hepatology · doi:10.1097/hep.0000000000000647 · Cited by 549
(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 545
Challenges and opportunities in NASH drug development
Harrison, S. A., Allen, A. M., Dubourg, J., Noureddin, M., & Alkhouri, N. (2023) · Nature Medicine · doi:10.1038/s41591-023-02242-6 · Cited by 353
Metabolic dysfunction-associated steatotic liver disease in adults
Huang, D. Q., Wong, V. W., Rinella, M. E., Boursier, J., Lazarus, J. V., Yki‐Järvinen, H., & Loomba, R. S. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00599-1 · Cited by 365
Impact of non-invasive biomarkers on hepatology practice: past, present and future
Anstee, Q. M., Castera, L., & Loomba, R. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.026 · Cited by 224
Sterling, R. K., Duarte‐Rojo, A., Patel, K., Asrani, S. K., Alsawas, M., Dranoff, J. A., Fiel, M. I., Murad, M. H., Leung, D. H., Levine, D., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000843 · Cited by 232
Mózes, F. E., Lee, J. A., Vali, Y., Alzoubi, O., Staufer, K., Trauner, M., Paternostro, R., Stauber, R. E., Holleboom, A. G., van Dijk, A.-M., et al. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(23)00141-3 · Cited by 214
Self-citationTincopa, M. A., & Loomba, R. S. (2023) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00066-3 · Cited by 163
Cao, Y.-T., Xiang, L.-L., Qi, F., Zhang, Y., Chen, Y., & Zhou, X. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101547 · Cited by 170
Ferraioli, G., Barr, R. G., Berzigotti, A., Sporea, I., Wong, V. W., Reiberger, T., Karlas, T., Thiele, M. S., Cardoso, A. C., Ayonrinde, O. T., et al. (2024) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2024.03.013 · Cited by 160
Ajmera, V. H., Kim, B. K., Yang, K. Y., Majzoub, A. M., Nayfeh, T., Tamaki, N., Izumi, N., Nakajima, A., Idılman, R., Gümüşsoy, M., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.073 · Cited by 141
Breakthroughs in therapies for NASH and remaining challenges
Ratziu, V., Francque, S., & Sanyal, A. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.04.002 · Cited by 132
Liang, J., Ampuero, J., Niu, H., Imajo, K., Noureddin, M., Behari, J., Lee, D. H., Ehman, R. L., Rorsman, F., Vessby, J., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.025 · Cited by 130
Nogueira, J. P., & Cusi, K. J. (2024) · Diabetes Spectrum · doi:10.2337/dsi23-0013 · Cited by 132
Boursier, J., Canivet, C. M., Costentin, C. E., Lannes, A., Delamarre, A., Stürm, N., Bail, B. L., Michalak, S., Oberti, F., Hilleret, M., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.02.059 · Cited by 109
Duseja, A. K., Singh, S. P., De, A., Madan, K., Rao, P. N., Shukla, A., Choudhuri, G., Saigal, S., Shalimar, S., Arora, A., et al. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.11.014 · Cited by 107
Pennisi, G., Enea, M., Pandolfo, A., Celsa, C., Antonucci, M., Ciccioli, C., Infantino, G., Mantia, C. L., Parisi, S., Tulone, A., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.06.013 · Cited by 90
Role of Ultrasound Methods for the Assessment of NAFLD
Petzold, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154581 · Cited by 78
Martinou, E., Pericleous, M., Stefanova, I., Kaur, V., & Angelidi, A. M. (2022) · Diagnostics · doi:10.3390/diagnostics12020407 · Cited by 89
Magnetic resonance elastography of the liver: everything you need to know to get started
Pepin, K. M., Welle, C. L., Guglielmo, F. F., Dillman, J. R., & Venkatesh, S. K. (2021) · Abdominal Radiology · doi:10.1007/s00261-021-03324-0 · Cited by 74
Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated
Atallah, E., Grove, J. I., Crooks, C. J., Burden‐Teh, E., Abhishek, A., Moreea, S., Jordan, K. M., Ala, A., Hutchinson, D. G., Aspinall, R., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.12.034 · Cited by 68
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial
Brennan, P. N., MacMillan, M., Manship, T., Moroni, F., Glover, A., Troland, D., MacPherson, I., Graham, C., Aird, R., Semple, S. I. K., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03406-8 · Cited by 66
Pennisi, G., Enea, M., Falco, V., Aithal, G. P., Palaniyappan, N., Yilmaz, Y. N., Boursier, J., Cassinotto, C., de Lédinghen, V., Chan, W., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000351 · Cited by 66
Liver Fibrosis in Asians With Metabolic Dysfunction–Associated Fatty Liver Disease
Sohn, W., Kwon, H., Chang, Y., Ryu, S., & Cho, Y. K. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.06.042 · Cited by 62
Kim, M. N., Han, J. W., An, J., Kim, B. K., Jin, Y., Kim, S., Lee, M., Lee, H. A., Cho, Y., Kim, H. Y., et al. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0506 · Cited by 65
Tamaki, N., Kurosaki, M., Huang, D. Q., & Loomba, R. S. (2022) · Hepatology Research · doi:10.1111/hepr.13764 · Cited by 62
Castéra, L., Garteiser, P., Laouenan, C., Vidal-Trécan, T., Vallet‐Pichard, A., Manchon, P., Paradis, V., Czernichow, S., Roulot, D. M., Larger, É., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.03.023 · Cited by 55
Caussy, C., Vergès, B. L., Leleu, D., Duvillard, L., Subtil, F., Klich, A., Hervieu, V., Milot, L. M., Segrestin, B., Bin, S., et al. (2025) · Diabetes Care · doi:10.2337/dc24-2075 · Cited by 55
Venkatesh, S. K., & Torbenson, M. S. (2022) · Abdominal Radiology · doi:10.1007/s00261-021-03396-y · Cited by 50
Noninvasive tests for liver fibrosis in 2024: are there different scales for different diseases?
Lai, J. C., Liang, L. Y., & Wong, G. L. (2023) · Gastroenterology report · doi:10.1093/gastro/goae024 · Cited by 50
Canivet, C. M., Costentin, C., Irvine, K. M., Delamarre, A., Lannes, A., Sturm, N., Oberti, F., Patel, P. J., Decaens, T., Irles‐Depé, M., et al. (2023) · Hepatology · doi:10.1002/hep.32665 · Cited by 49
Lonardo, A., Singal, A. K., Osna, N. A., & Kharbanda, K. K. (2022) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2022.14 · Cited by 49
Zheng, Y., Zhao, L., Xiong, Z., Huang, C., Yong, Q., Fang, D., Fu, Y., Gu, S., Chen, C., Li, J., et al. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0047 · Cited by 53
Kim, M., Yoon, E. L., Cho, S., Lee, C., Kang, B., Park, H., Jun, D. W., & Nah, E. (2022) · Liver International · doi:10.1111/liv.15259 · Cited by 43
Matrix stiffness-driven cancer progression and the targeted therapeutic strategy
Liang, R., & Song, G. (2023) · Mechanobiology in Medicine · doi:10.1016/j.mbm.2023.100013 · Cited by 49
Ito, T., Nguyen, V. H., Tanaka, T., Park, H., Yeh, M., Kawanaka, M., Arai, T., Atsukawa, M., Yoon, E. L., Tsai, P., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.05.015 · Cited by 41
Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives
Clayton‐Chubb, D., Kemp, W. W., Majeed, A., Lubel, J. S., Hodge, A., & Roberts, S. K. (2023) · Nutrients · doi:10.3390/nu15030687 · Cited by 45
Wajcman, D. I., Isakov, N. F., Grinshpan, L. S., Salomone, F., Lazarus, J. V., Webb, M., Shibolet, O., Kariv, R., & Zelber‐Sagi, S. (2022) · Nutrients · doi:10.3390/nu14173533 · Cited by 39
Tantu, M. T., Farhana, F. Z., Haque, F., Koo, K. M., Qiao, L., Ross, A. G., & Shiddiky, M. J. A. (2025) · npj gut and liver. · doi:10.1038/s44355-025-00030-2 · Cited by 45
Liu, W., Huang, S., Ji, H., Kim, S. U., Yip, T. C., Wong, G. L., Petta, S., Tsochatzis, E. A., Nakajima, A., Bugianesi, E., et al. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.02.034 · Cited by 38
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
Francisco Barrera, M., Uribe, J., Olvares, N., Huerta, P., Cabrera, D., & Romero‐Gómez, M. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101501 · Cited by 38
Chon, Y. E., Jin, Y., An, J., Kim, H. Y., Choi, M., Jun, D. W., Kim, M. N., Han, J. W., Lee, H. A., Yu, J. H., et al. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0392 · Cited by 36
Țâru, M.-G., Leucuta, D.-C., Lupșor‐Platon, M., Turco, L., Ferri, S., Hashim, A., Orasan, O. H., Procopeț, B., Ştefănescu, H., Morelli, M. C., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000001190 · Cited by 43
Argalia, G., Ventura, C., Tosi, N., Campioni, D., Tagliati, C., Tufillaro, M., Cucco, M., Svegliati‐Baroni, G., & Giovagnoni, A. (2022) · La radiologia medica · doi:10.1007/s11547-022-01475-8 · Cited by 35
Ballestri, S., Mantovani, A., Girolamo, M. D., Baldelli, E., Capitelli, M., & Lonardo, A. (2023) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2022.23 · Cited by 33
Endpoints in NASH Clinical Trials: Are We Blind in One Eye?
Lonardo, A., Ballestri, S., Mantovani, A., Targher, G., & Bril, F. (2024) · Metabolites · doi:10.3390/metabo14010040 · Cited by 34
Liu, Z., Chen, J., Jo, M., Viola Vogel, B., Chen, J., Rogers, J. A., & Li, S. (2026) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00391-6 · Cited by 42
Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?
Canivet, C. M., & Boursier, J. (2022) · Diagnostics · doi:10.3390/diagnostics13010091 · Cited by 35
Cao, H., Ke, B., Lin, F., Xue, Y., & Fang, X. (2023) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2023.01.003 · Cited by 33
Moreira, R. O., Valério, C. M., Villela‐Nogueira, C. A., Cercato, C., Gerchman, F., Lottenberg, A. M., Godoy‐Matos, A. F., Oliveira, R. D. A., Brandão‐Mello, C. E., Álvares‐da‐Silva, M. R., et al. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2023-0123 · Cited by 45
Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions
Kadi, D., Loomba, R. S., & Bashir, M. R. (2024) · Radiology · doi:10.1148/radiol.222695 · Cited by 32
Wang, Y., Song, S. J., Jiang, Y., Lai, J. C., Wong, G. L., Wong, V. W., & Yip, T. C. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0246 · Cited by 32
Bilson, J., Scorletti, E., Bindels, L. B., Afolabi, P. R., Targher, G., Calder, P. C., Sethi, J. K., & Byrne, C. D. (2021) · Nutrition and Diabetes · doi:10.1038/s41387-021-00170-3 · Cited by 30
Magnetic resonance elastography: from invention to standard of care
Ehman, R. L. (2022) · Abdominal Radiology · doi:10.1007/s00261-022-03597-z · Cited by 32
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease
Díaz, L. A., Thiele, M. S., Louvet, A., Lee, B. P., Ajmera, V. H., Tavaglione, F., Hsu, C. L., Huang, D. Q., Pose, E., Bataller, R. A., et al. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01120-5 · Cited by 33
Thanapirom, K., Suksawatamnuay, S., Tanpowpong, N., Chaopathomkul, B., Sriphoosanaphan, S., Thaimai, P. M., Srisoonthorn, N., Treeprasertsuk, S., & Komolmit, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-08955-x · Cited by 31
Kamada, Y., Nakamura, T., Isobe, S., Hosono, K., Suama, Y., Ohtakaki, Y., Nauchi, A., Yasuda, N., Mitsuta, S., Miura, K., et al. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01932-1 · Cited by 31
Younossi, Z. M., Alkhouri, N., Cusi, K., Isaacs, S. D., Kanwal, F., Noureddin, M., Loomba, R. S., Ravendhran, N., Lam, B. P., Nader, K., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17346 · Cited by 31
Li, J., Lu, X., Zhu, Z. H., Kalutkiewicz, K. J., Mounajjed, T., Therneau, T. M., Venkatesh, S. K., Sui, Y., Glaser, K. J., Hoodeshenas, S., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000417 · Cited by 30
Karjoo, S., Auriemma, A., Fraker, T. R., & Bays, H. E. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100027 · Cited by 33
Esteatohepatitis no alcohólica
Romero‐Gómez, M. (2022) · Medicina Clínica · doi:10.1016/j.medcli.2022.06.017 · Cited by 32
Dalbeni, A., Lombardi, R., Henrique, M. K. C. L., Zoncapè, M., Pennisi, G., Petta, S., Tateishi, R., Keklikkıran, Ç., Colecchia, A., Sacerdoti, D., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000694 · Cited by 29
Suresh, M. G., Mohamed, S., Geetha, H. S., Prabhu, S., Trivedi, N., Ng, Z. C., Mehta, P. D., Brar, A. S., Sohal, A., Goyal, M. K., et al. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i2.113149 · Cited by 30
Payne, J. Y., Alkhouri, N., Le, P., Rothberg, M. B., Polanco, P., Sakkal, C., & Dasarathy, S. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000019 · Cited by 28
Clinical Significance of Liver MR Imaging
Ichikawa, S., & Goshima, S. (2023) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.rev.2022-0100 · Cited by 27
Kanwal, F., Bril, F., Wong, V. W., Adams, L. A., Pfotenhauer, K. M., SKOLNIK, N., Wright, E. E., Eckel, R. H., Noureddin, M., Loomba, R. S., et al. (2026) · Gastroenterology · doi:10.1053/j.gastro.2026.01.047 · Cited by 37
Hanniman, E. A., Costa, A. F., Bowen, C. V., Abdolell, M., Stueck, A., McLeod, M., Peltekian, K. M., Rioux, J., & Clarke, S. E. (2022) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28154 · Cited by 27
Autoimmune Hepatitis and Fibrosis
Pellicano, R., Ferro, A., Cicerchia, F., Mattivi, S., Fagoonee, S., & Durazzo, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051979 · Cited by 28
MR Elastography: Practical Questions, From the AJR Special Series on Imaging of Fibrosis
Yin, M., & Ehman, R. L. (2023) · American Journal of Roentgenology · doi:10.2214/ajr.23.29437 · Cited by 26
Non-Invasive Tests as a Replacement for Liver Biopsy in the Assessment of MASLD
Frączek, J., Sowa, A., Agopsowicz, P., Migacz, M., Dylińska-Kala, K., & Holecki, M. T. (2025) · Medicina · doi:10.3390/medicina61040736 · Cited by 26
Țâru, M.-G., Neamți, L., Țâru, V., Procopciuc, L. M., Procopeț, B., & Lupșor‐Platon, M. (2023) · Diagnostics · doi:10.3390/diagnostics13040788 · Cited by 25
Population screening for cirrhosis
Thiele, M. S., Pose, E., Juanola, A., Mellinger, J. L., & Ginès, P. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000512 · Cited by 25
Shumbayawonda, E., French, M., Carolan, J. E., Beyer, C., Lorgelly, P. K., Tonev, D., Banerjee, R., Miller, M. H., Byrne, C. D., Patel, J., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00796-9 · Cited by 24
Zhang, Y., Feng, Y., You, C.-L., & Zhang, L. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04017-4 · Cited by 27
Jia, S., Ye, X., Wu, T., Wang, Z. M., & Wu, J. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04314-y · Cited by 24
Cai, X., Gao, J. S., Liu, S., Wang, M., Hu, J., Hong, J., Zhu, Q., Tuerxun, G., Dang, Y., & Li, N. (2022) · Disease Markers · doi:10.1155/2022/3150380 · Cited by 24
Noureddin, N., Ajmera, V. H., Bergstrom, J., Bettencourt, R., Huang, D. Q., Siddiqi, H., Majzoub, A. M., Nayfeh, T., Tamaki, N., Izumi, N., et al. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17707 · Cited by 24
Exploring the links between types 2 diabetes and liver‐related complications: A comprehensive review
Sanchez, L. O., Chen, Y., Lassailly, G., & Qi, X. (2023) · United European Gastroenterology Journal · doi:10.1002/ueg2.12508 · Cited by 26
MAFLD in adults: non-invasive tests for diagnosis and monitoring of MAFLD
Chan, W., Wong, V. W., Adams, L. A., & Nguyen, M. H. (2024) · Hepatology International · doi:10.1007/s12072-024-10661-x · Cited by 24
Pericàs, J. M., Tacke, F., Anstee, Q. M., Prospero, N. A. D., Kjær, M. S., Mesenbrink, P. G., König, F., Genescà, J., & Ratziu, V. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.09.021 · Cited by 23
Identification of high-risk subjects in nonalcoholic fatty liver disease
Stern, C., & Castéra, L. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0431 · Cited by 24
Liver Magnetic Resonance Elastography: Focus on Methodology, Technique, and Feasibility
Zerunian, M., Masci, B., Caruso, D., Pucciarelli, F., Polici, M., Nardacci, S., Santis, D. D., Iannicelli, E., & Laghi, A. (2024) · Diagnostics · doi:10.3390/diagnostics14040379 · Cited by 23
Bril, F., & Gray, M. E. (2023) · Obesity · doi:10.1002/oby.23960 · Cited by 22
Li, C., Wang, Y., Bai, R., Zhao, Z., Li, W., Zhang, Q., Zhang, C., Yang, W. J., Liu, Q., Su, N., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102881 · Cited by 22
Yang, S., Cheng, J., Zhang, R., Sun, H., Zhang, H., Lyu, S., & Duan, W. (2021) · Hepatology Research · doi:10.1111/hepr.13728 · Cited by 21
Torres, L., Schuch, A., Longo, L., Valentini, B. B., Galvão, G. S., Luchese, E., Pinzon, C., Bartels, R., & Álvares‐da‐Silva, M. R. (2022) · Annals of Hepatology · doi:10.1016/j.aohep.2022.100774 · Cited by 21
Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary
Villani, R., Lupo, P., Sangineto, M., Romano, A. D., & Serviddio, G. (2023) · Diagnostics · doi:10.3390/diagnostics13071236 · Cited by 21
Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure
Inciardi, R. M., Mantovani, A., & Targher, G. (2023) · Current Heart Failure Reports · doi:10.1007/s11897-023-00613-1 · Cited by 25
Bauer, D. J. M., Nixdorf, L., Dominik, N., Schwarz, M., Hofer, B., Hartl, L., Semmler, G., Jachs, M., Simbrunner, B., Jedamzik, J., et al. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18019 · Cited by 21
Eguchi, A., Iwasa, M., Yamada, M., Tamai, Y., Shigefuku, R., Hasegawa, H., HIROKAWA, Y. S., Hayashi, A., Okuno, K., Matsushita, Y., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1971 · Cited by 21
Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Gómez, C., Melo, L., Aguado, D. M., & Bataller, R. A. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0017 · Cited by 20
Nishio, T., Taura, K., Koyama, Y., Ishii, T., & Hatano, E. (2023) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12692 · Cited by 19
Magnetic Resonance Imaging in Clinical Trials of Diabetic Kidney Disease
Friedli, I., Baid‐Agrawal, S., Unwin, R. J., Morell, A., Johansson, L., & Hockings, P. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144625 · Cited by 21
Non-contact elastography methods in mechanobiology: a point of view
Caponi, S., Passeri, A. A., Capponi, G., Fioretto, D., Vassalli, M., & Mattarelli, M. (2021) · European Biophysics Journal · doi:10.1007/s00249-021-01567-9 · Cited by 20
Țâru, M.-G., Tefas, C., Neamți, L., Minciună, I., Țâru, V., Maniu, A., Rusu, I., Petrushev, B., Procopciuc, L. M., Leucuta, D., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303971 · Cited by 20
Optimizing liver health before and after gene therapy for hemophilia A
Ragni, M. V., Mead, H., de Jong, Y. P., Kaczmarek, R., Leavitt, A. D., Long, B. R., Nugent, D. J., Sabatino, D. E., Fong, S., von Drygalski, A., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024013059 · Cited by 20
Non-invasive tests for fibrotic MASH for reducing screen failure in therapeutic trials
Fichez, J., Mouillot, T., Vonghia, L., Costentin, C. E., Moreau, C., Roux, M., Delamarre, A., Francque, S., Zheng, M., & Boursier, J. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101351 · Cited by 18
Metadata
- Authors
- Selvaraj, E. A., Mózes, F. E., Jayaswal, A. N. A., Zafarmand, M. H., Vali, Y., Lee, J. A., Levick, C. K., Young, L. A. J., Palaniyappan, N., Liu, C.-H., Aithal, G. P., Romero-Gómez, M., Brosnan, M. J., Tuthill, T. A., Anstee, Q. M., Neubauer, S., Harrison, S. A., Bossuyt, P. M., Pavlides, M., Anstee, Q., Daly, A., Johnson, K., Govaere, O., Cockell, S., Tiniakos, D., Bedossa, P., Oakley, F., Cordell, H., Day, C., Wonders, K., Bossuyt, P., Zafarmand, H., Vali, Y., Lee, J., Ratziu, V., Clement, K., Pais, R., Schuppan, D., Schattenberg, J., Vidal-Puig, T., Vacca, M., Rodrigues-Cuenca, S., Allison, M., Kamzolas, I., Petsalaki, E., Oresic, M., Hyötyläinen, T., McGlinchey, A., Mato, J. M., Millet, O., Dufour, J.-F., Berzigotti, A., Pavlides, M., Harrison, S., Neubauer, S., Cobbold, J., Mozes, F., Akhtar, S., Banerjee, R., Kelly, M., Shumbayawonda, E., Dennis, A., Erpicum, C., Romero-Gómez, M., Gómez-González, E., Ampuero, J., Castell, J., Gallego-Durán, R., Fernández, I., Montero-Vallejo, R., Karsdal, M., Erhardtsen, E., Rasmussen, D., Leeming, D. J., Fisker, M. J., Sinisi, A., Musa, K., Betsou, F., Sandt, E., Tonini, M., Bugianesi, E., Rosso, C., Armandi, A., Marra, F., Gastaldelli, A., Svegliati, G., Boursier, J., Francque, S., Vonghia, L., Ekstedt, M., Kechagias, S., Yki-Jarvinen, H., Luukkonen, P., van Mil, S., Papatheodoridis, G., Cortez-Pinto, H., Valenti, L., Petta, S., Miele, L., Geier, A., Trautwein, C., Aithal, G., Hockings, P., Newsome, P., Wenn, D., Pereira Rodrigues, C. M., Chaumat, P., Hanf, R., Trylesinski, A., Ortiz, P., Duffin, K., Brosnan, J., Tuthill, T., McLeod, E., Ertle, J., Younes, R., Ostroff, R., Alexander, L., Kjær, M. S., Mikkelsen, L. F., Balp, M.-M., Brass, C., Jennings, L., Martic, M., Loeffler, J., Hanauer, G., Shankar, S., Fournier, C., Pepin, K., Ehman, R., Myers, J., Ho, G., Torstenson, R., Myers, R., & Doward, L.
- Affiliations
- University of Oxford (GB)
- Nottingham University Hospitals NHS Trust (GB)
- Pfizer (United States) (US)
- Amsterdam University Medical Centers (NL)
- Instituto de Biomedicina de Sevilla (ES)
- ORCID
- Selvaraj, Emmanuel Anandraj
- Jayaswal, Arjun Narayan Ajmer
- Lee, Jenny A.
- Levick, Christina Kim
- Young, Liam Arnold Joseph
- Palaniyappan, Naaventhan
- Liu, Chang-Hai
- Aithal, Guruprasad Padur
- Tuthill, Theresa A.
- Anstee, Quentin M.
- Daly, Ann
- Johnson, Katherine
- Govaere, Olivier
- Cockell, Simon
- Tiniakos, Dina
- Oakley, Fiona
- Cordell, Heather
- Day, Chris
- Wonders, Kristy
- Ratziu, Vlad
- Pais, Raluca
- Schuppan, Detlef
- Schattenberg, Jörn
- Kamzolas, Ioannis
- Petsalaki, Evangelia
- Hyötyläinen, Tuulia
- Dufour, Jean-François
- Berzigotti, Annalisa
- Cobbold, Jeremy
- Banerjee, Rajarshi
- Kelly, Matt
- Shumbayawonda, Elizabeth
- Dennis, Andrea
- Gómez-González, Emilio
- Ampuero, Javier
- Karsdal, Morten
- Rasmussen, Daniel
- Betsou, Fay
- Bugianesi, Elisabetta
- Rosso, Chiara
- Armandi, Angelo
- Marra, Fabio
- Gastaldelli, Amalia
- Boursier, Jérôme
- Francque, Sven
- Vonghia, Luisa
- Ekstedt, Mattias
- Kechagias, Stergios
- Luukkonen, Panu
- Papatheodoridis, George
- Valenti, Luca
- Petta, Salvatore
- Miele, Luca
- Geier, Andreas
- Trautwein, Christian
- Hockings, Paul
- Newsome, Philip
- Ortiz, Pablo
- Duffin, Kevin
- Ertle, Judith
- Younes, Ramy
- Ostroff, Rachel
- Alexander, Leigh
- Kjær, Mette Skalshøi
- Mikkelsen, Lars Friis
- Balp, Maria-Magdalena
- Jennings, Lori
- Loeffler, Juergen
- Shankar, Sudha
- Fournier, Céline
- Pepin, Kay
- Ehman, Richard
- Ho, Gideon
- Doward, Lynda
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2021-10
- Volume
- 75
- Issue
- 4
- Pages
- 770-785
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3161701468
- Cited by
- 376
- References
- 107
- Citations by year
- 2026: 67 · 2025: 84 · 2024: 77 · 2023: 81 · 2022: 52 · 2021: 14
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Deposito de Investigacion Universidad de Sevilla (University of Seville) (publishedVersion, cc-by-nc-nd)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by-nc-nd)
- Repository@Nottingham (University of Nottingham) (acceptedVersion, other-oa)
- Florence Research (University of Florence) (submittedVersion, cc-by-nc-nd)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by-nc-nd)
- Lirias (KU Leuven) (submittedVersion, cc-by-nc-nd)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by-nc-nd)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, cc-by-nc-nd)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, cc-by-nc-nd)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc-nd)
- Funders
- European Federation of Pharmaceutical Industries and Associations
- Innovative Medicines Initiative (777377)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Ultrasound Imaging and Elastography
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- non-alcoholic fatty liver disease, liver fibrosis, nonalcoholic steatohepatitis, vibration-controlled transient elastography, point shear wave elastography, two-dimensional shear wave elastography, magnetic resonance elastography, magnetic resonance imaging, noninvasive fibrosis assessment, liver cirrhosis, diagnostic accuracy
- MeSH terms
- Adult, Humans, Magnetic Resonance Imaging, ROC Curve, Area Under Curve, Elasticity Imaging Techniques, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
